Global Gene Therapy Market Analysis, Phases, Key Company and Forecast to 2022

Global Gene Therapy Market Analysis & Forecast to 2022 research report provides Gene Therapy Phases, Strength of Gene Therapy Industry, Vectors for Gene Delivery, Clinical Applications, Key Company analysis and forecasts to 2022

Pune, India - November 14, 2018 /MarketersMedia/ —

In 2017, the gene therapy market for technologies, services and products was estimated to be worth $x million, with a potential to reach $363 million by 2022. The main market space is cancer which currently holds x% market share. This indication generated $x million in 2017 and will generate $x million in 2022. This is followed by rare diseases, cardiovascular, neurological and ocular indications. Looking at the market by technology, at present, gene product therapeutics generate the majority of revenue with over $x million in 2017, growing to $x million by 2022. Viral vectors are set to generate $x million in 2017, and will rise to $x million in 2022, and by then gene therapy services such as vector development and transfection will hit $x million. At present, the Americas have penetrated the market significantly with 65% geographic share, followed by Europe (x%) and the RoW (x%).

Company Profiles: 4d Molecular Therapeutics LLC, Abeona Therapeutics LLC, Advanced Cell & Gene Therapy LLC, Advantagene Inc., Adverum Biotechnologies Inc., Addgene Inc., Agilis Biotherapeutics LLC, Angionetics Inc., Applied Genetic Technologies Corporation (AGTC), AnGes MG Inc., Asklepios BioPharmaceutical Inc., Audentes Therapeutics Inc. and others…

Get Discount on Gene Therapy Market Analysis & Forecast to 2022 Report at https://www.reportsnreports.com/contacts/discount.aspx?name=1370259

This report provides the reader with:

• Current Global Market Worth and Forecast with CAGR Through 2022
• Sub-Market Worth by Therapeutic Area (Cancer, Rare Diseases, Cardiovascular, Neurological, Ocular) and Forecast with CAGR Through 2022
• Sub-Market Worth by Geography (Americas, Europe, RoW) and Forecast with CAGR Through 2022
• Sub-Market Worth by Technology (Gene Product, Service, Viral Vectors) and Forecast with CAGR Through 2022
• Insight into gene therapy technologies, challenges associated with developing therapeutic genes and disadvantages of gene therapy.
• Full outline of the gene therapy industry from the formative years through to products discovered during 1990 and 2017.
• Detailed descriptions of commercialized products approved between 2003 and 2017 that include: Gendicine, Rexin-G, Oncorine, Neovasculgen, Glybera, Imlygic, Strimvelis, Zalmoxis, Kymriah, Yescarta and Luxturna.
• Description of seven of the Phase III product candidates that include: Generx, Collategene, LentiGlobin, Lenti-D, VM-202, Invosa and GS-010.
• Description of 21 Phase II product candidates that are set to have significant market share.
• Commercialization status of gene therapies in by geographic region
• Evaluation of gene therapy pricing
• Description of the firstever warranty offer by GSK for Strimvelis.
• A detailed analysis of various types of viruses used as vectors.
• Description of clinical applications of gene therapy and the various genetic and infectious diseases addressed by gene therapy.
• Description of 77 companies that are directly and indirectly associated with gene therapy industry.

Order a Complete Research Study of Gene Therapy Market Report at https://www.reportsnreports.com/purchase.aspx?name=1370259

Key Questions Answered in this Report:

• What is the size of gene therapy market?
• What is the CAGR and market size over the next five years?
• What are the different sub-markets and their worth/CAGR over the next five years?
• What is gene augmentation therapy?
• What is suicide gene therapy?
• How is ex vivo gene delivery different from in vivo gene delivery?
• What are the types of gene therapies classified on the basis of targeted cell types?
• What is the role of CRISPR technology in gene therapy?
• What are the approved gene therapy products?
• How many gene therapy product candidates have reached the Phase III stage?
• How many Phase II gene therapy product candidates are there?
• What is the commercialization status of gene therapies in E.U. member countries?
• What are the prices of gene therapy products?
• What are the reasons for this extortionate pricing of gene therapies?
• Which company is offering warranty for its gene- therapy product?
• What is the current strength of gene therapy industry?
• Is it true that the real strength of gene therapy industry is based on the number of clinical trials?
• What is the total number of ongoing clinical trials as of 2017?
• What is the distribution of clinical trials by geography?
• Which countries are associated with gene therapy clinical trials?
• What are the major indications addressed by the clinical trials?
• Which genes are transferred in these clinical trials?
• How many Big Pharma are associated with the Gene Therapy Industry?
• What are non-viral and viral vectors?
• What are the various features of viral vectors?
• Which viral vectors are predominantly used in gene therapy clinical trials?
• What are the major diseases addressed by therapeutic genes?
• Where is the gene therapy market heading, and what opportunities and challenges will it face?

Table of Contents:
1.0 Introduction
2.0 Gene Therapy: The Basics
3.0 Historic Overview of Gene Therapy
4.0 Gene Therapy Phase III Product Candidates
5.0 Gene Therapy Phase II Product Candidates
6.0 Commercialization, Cost and Warranty of Gene Therapies
7.0 The Strength of Gene Therapy Industry
8.0 Vectors for Gene Delivery
9.0 Clinical Applications of Gene Therapy
10.0 Market Analysis
11.0 Manufacturing of Viral Vectors and Logistics
12.0 Company Profiles

Contact Info:
Name: Hrishikesh Patwardhan
Email: Send Email
Organization: ReportsnReports

Source URL: https://marketersmedia.com/global-gene-therapy-market-analysis-phases-key-company-and-forecast-to-2022/443554

For more information, please visit https://www.reportsnreports.com/reports/1370259-global-gene-therapy-market-analysis-forecast-to-2022.html

Source: MarketersMedia

Release ID: 443554

More News From sports.morningdispatcher.com

Butt hopes for Pakistan return, replaces Hafeez in PSL

Feb 20, 2019

ISLAMABAD — Salman Butt is hoping to make a national team comeback after replacing the injured Mohammad Hafeez in the Pakistan Super League. The left-handed opening batsman spoke in Lahore on Wednesday before leaving for the United Arab Emirates to represent Lahore Qalandars in the PSL. "I really hope that if I can come good and help the team win then definitely the other things will work out," Butt said. Hafeez was ruled out of the PSL after he fractured his right thumb against Karachi Kings last Saturday. AB de Villiers will take over as captain in his absence. "These...

No. 1 Naomi Osaka loses 1st match since splitting from coach

Feb 20, 2019

DUBAI, United Arab Emirates — Naomi Osaka lost her first match since moving up to No. 1 in the WTA rankings — and first since splitting from her coach. The two-time major champion had trouble with her serve and was beaten 6-3, 6-3 by 67th-ranked Kristina Mladenovic at the Dubai Championships in a little more than an hour on Tuesday. Afterward, Osaka wiped away tears while speaking to reporters and discussing the difficulty of dealing with her new-found spot atop the sport. "I don't think I necessarily understand what position I'm in, in a way. Because last year, I wasn't...

AP Photos: Centuries-old Indian pole wrestling goes global

Feb 20, 2019

MUMBAI, India — Is it gymnastics? Is it yoga? Is it even a sport? Picture a person climbing a coconut tree. Now imagine the person twisting, turning, rotating and practicing yoga postures, all while firmly gripping the tree with the thighs. Mallakhamb is this and more. Mallakhamb is a traditional training exercise for wrestlers in India, and its name comes from the words malla, meaning wrestler, and khamb, or pole. Now after centuries of being practiced in isolation in the subcontinent, mallakhamb is set to have its first international championship this weekend in the capital of the western Indian state...

PSL: A pathway to revive international cricket in Pakistan

Feb 20, 2019

ISLAMABAD — The Pakistan Super League is not like any other Twenty20 cricket competition. It can't compete financially with the lucrative Indian Premier League in terms of player payments, yet it's a dream for some cricketers just to be playing in it. For the Pakistan Cricket Board, it's considered a pathway to resuming fully-fledged international cricket on home soil. It has been nearly a decade since a terrorist attack on the Sri Lanka team bus at Lahore in 2009 resulted in the suspension of international cricket in Pakistan, forcing the national team to play its 'home' games in the United...

Coach backs Sarfraz to lead Pakistan at Cricket World Cup

Feb 20, 2019

ISLAMABAD — Pakistan coach Mickey Arthur says it's time to move on from captain Sarfraz Ahmed's four-match ban for a racial taunt and concentrate on finalizing the team for the Cricket World Cup. Sarfraz was reaffirmed on Tuesday as captain to the end of the World Cup in July, despite the Pakistan Cricket Board saying its policy was to name the captain on a series-to-series basis. Pakistan media have questioned the Sarfraz decision, including whether it was a political riposte at the ICC for banning Sarfraz. Private broadcaster Geo News wondered whether the PCB did a U-turn or succumbed to...

About Us

Get all the up-to-date breaking news about politics, business, entertainment, sports, lifestyles, weather, traffic, and local news in a seamless digital environment only in Morning Dispatcher.

Contact us: sales[at]morningdispatcher.com

Subscribe Now!

Quick Links

HomePress